A COMPREHENSIVE STUDY OF THE RELATION BETWEEN SERUM CONCENTRATIONS, CONCENTRATION RATIOS, AND LEVEL/DOSE RATIOS OF CARBAMAZEPINE AND ITS METABOLITES WITH AGE, WEIGHT, DOSE, AND CLEARANCES IN EPILEPTIC CHILDREN

被引:10
作者
LIU, H [1 ]
DELGADO, MR [1 ]
机构
[1] UNIV TEXAS,TEXAS SCOTTISH RITE HOSP CHILDREN,SW MED CTR,DEPT NEUROL,DALLAS,TX 75219
关键词
EPILEPSY; CARBAMAZEPINE; CARBAMAZEPINE-DIOL; SERUM CONCENTRATIONS; DOSE; CHILDREN;
D O I
10.1111/j.1528-1157.1994.tb01793.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We made a comprehensive study of the relation between age, weight, carbamazepine (CBZ) dose, total clearance (TC), and intrinsic clearance (IC) and concentrations, concentration ratios, and level/dose ratios of CBZ, carbamazepine-10,11-epoxide (CBZ-E) and trans-10,11-dihydroxy-10,11-dihydro-carbamazepine (CBZ-H) in a group of epileptic children receiving CBZ monotherapy. Body weight and age showed negative correlations with TC, IC, CBZ dose, and CBZ-E/CBZ and CBZ-H/CBZ concentration ratios, and had positive relation with CBZ, CBZ-E, and CBZ-H level/dose ratios. These results indicate decreased CBZ metabolism with patient maturity. Correlations between CBZ dose with TC, IC, and the concentration ratios of CBZ-E/CBZ, CBZ-H/CBZ-E, and CBZ-H/CBZ were positive. CBZ dose also had negative associations with CBZ and CBZ-E level/dose ratios, indicating dose-dependent autoinduction of CBZ metabolism. Our data suggest that weight, age, and CBZ dose have less influence on epoxide-hydrolase activities than on epoxidase activities. The CBZ-E/CBZ concentration ratio can be used as an indicator of the degree of autoinduction of CBZ metabolism, even in patients receiving CBZ monotherapy.
引用
收藏
页码:1221 / 1229
页数:9
相关论文
共 32 条
[1]  
AGBATO GA, 1986, ARCH NEUROL-CHICAGO, V43, P111
[2]   FACTORS INFLUENCING SERUM LEVELS OF CARBAMAZEPINE AND CARBAMAZEPINE-10,11-EPOXIDE IN CHILDREN [J].
ALTAFULLAH, I ;
TALWAR, D ;
LOEWENSON, R ;
OLSON, K ;
LOCKMAN, LA .
EPILEPSY RESEARCH, 1989, 4 (01) :72-80
[3]   CLINICAL PHARMACOKINETICS AND PHARMACOLOGICAL EFFECTS OF CARBAMAZEPINE AND CARBAMAZEPINE-10,11-EPOXIDE - AN UPDATE [J].
BERTILSSON, L ;
TOMSON, T .
CLINICAL PHARMACOKINETICS, 1986, 11 (03) :177-198
[4]   CLINICAL PHARMACOKINETICS OF CARBAMAZEPINE [J].
BERTILSSON, L .
CLINICAL PHARMACOKINETICS, 1978, 3 (02) :128-143
[5]  
BOURGEOIS BFD, 1984, THER DRUG MONIT, V6, P259, DOI 10.1097/00007691-198409000-00001
[6]   CARBAMAZEPINE METABOLISM IN MAN INDUCTION AND PHARMACOGENETIC ASPECTS [J].
EICHELBAUM, M ;
TOMSON, T ;
TYBRING, G ;
BERTILSSON, L .
CLINICAL PHARMACOKINETICS, 1985, 10 (01) :80-90
[7]  
EICHELBAUM M, 1979, CLIN PHARMACOL THER, V26, P366
[8]   FACTORS INFLUENCING SIMULTANEOUS CONCENTRATIONS OF TOTAL AND FREE CARBAMAZEPINE AND CARBAMAZEPINE-10, 11-EPOXIDE IN SERUM OF CHILDREN WITH EPILEPSY [J].
ELYAS, AA ;
PATSALOS, PN ;
AGBATO, OA ;
BRETT, EM ;
LASCELLES, PT .
THERAPEUTIC DRUG MONITORING, 1986, 8 (03) :288-292
[9]  
Faigle JW, 1989, ANTIEPILEPTIC DRUGS, P491
[10]   CARBAMAZEPINE AND CARBAMAZEPINE-10,11-EPOXIDE SERUM CONCENTRATIONS IN EPILEPTIC CHILDREN [J].
FURLANUT, M ;
MONTANARI, G ;
BONIN, P ;
CASARA, GL .
JOURNAL OF PEDIATRICS, 1985, 106 (03) :491-495